<table class="table table-bordered table-hover table-condensed">
<thead><tr><th title="Field #1">Distributor</th>
<th title="Field #2">Base acrylic resin</th>
<th title="Field #3">Additives</th>
</tr></thead>
<tbody><tr>
<td>A</td>
<td>Paraloid® B44</td>
<td>Very low amounts of substituted benzotriazole, epoxidized soybean oil</td>
</tr>
<tr>
<td>B</td>
<td>Paraloid® B44</td>
<td>Substituted benzotriazole, epoxidized soybean oil</td>
</tr>
<tr>
<td>C</td>
<td>Paraloid® B44</td>
<td>Substituted benzotriazole, epoxidized soybean oil</td>
</tr>
<tr>
<td>D</td>
<td>Different resin, possibly Paraloid® B48N</td>
<td>Substituted benzotriazole, epoxidized soybean oil</td>
</tr>
<tr>
<td>E</td>
<td>Paraloid® B44</td>
<td>Substituted benzotriazole, epoxidized soybean oil</td>
</tr>
<tr>
<td>F</td>
<td>Paraloid® B44</td>
<td>Substituted benzotriazole, epoxidized soybean oil</td>
</tr>
</tbody></table>

<p>Table 37.1. Incralac formulations based on FTIR analysis</p>
